Since we have previously demonstrated that a few sequence variants in the p16INK4a 5′UTR found in melanoma patients can have a negative functional impact, potentially acting at post-transcriptional level [28], we hypothesized that p16INK4a 5′UTR might contain specific sequence and structural features that can drive cap-independent translation. This evidence concerns the gene CDKN2A and melanoma.